PHI with Biliary cirrhosis
How does this condition affect your private health insurance?
Biliary cirrhosis, more accurately termed Primary Biliary Cholangitis (PBC), is a chronic autoimmune liver disease characterized by the progressive destruction of small bile ducts within the liver. This destruction leads to cholestasis, where bile accumulates and damages liver cells, eventually causing inflammation, fibrosis, and ultimately cirrhosis. Symptoms often include fatigue, pruritus (itching), and jaundice, but many individuals are asymptomatic for years. If left untreated, PBC can lead to severe liver failure and necessitate a liver transplant. Early diagnosis and treatment with ursodeoxycholic acid are crucial to slow disease progression and improve outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms often develop insidiously over months to several years, with initial noticeable symptoms persisting for weeks to months.
Duration of Illness (Lifetime)
Chronic, progressive disease requiring lifelong management.
Cost of Treatment (Initial)
Initial diagnostic workup (blood tests, imaging, biopsy) and early medication can range from several hundreds to a few thousands of Euros/Dollars, depending on the healthcare system and extent of tests.
Cost of Treatment (Lifetime)
Lifelong medication (e.g., ursodeoxycholic acid), regular monitoring (blood tests, imaging), management of complications, and potentially a liver transplant which can cost hundreds of thousands to millions.
Mortality Rate
Significant, especially without effective treatment or in advanced stages leading to liver failure. With treatment, survival is improved but still lower than the general population.
Risk of Secondary Damages
Very high. Common complications include osteoporosis, portal hypertension, varices, ascites, hepatic encephalopathy, vitamin deficiencies, severe fatigue, pruritus, and increased risk of hepatocellular carcinoma.
Probability of Full Recovery
Very low to none. PBC is a progressive disease; treatment aims to slow its progression, not to achieve a complete cure.
Underlying Disease Risk
High. PBC is frequently associated with other autoimmune conditions, most commonly Sjögren's syndrome, but also rheumatoid arthritis, thyroid disease, scleroderma, and celiac disease.